JAZZ - Jazz Pharmaceuticals Explores Asset Sale Option Possibly Cannabinoid Business: Report | Benzinga
Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is reportedly exploring strategic options comprising a potential sale.
The company is talking to advisers to help field interest and is also exploring possibilities to include a breakup or divestment of parts of the business, reported Bloomberg.
As per the report, there is a possibility of separating ...